The third phase human trial of Covaxin, the much-awaited indigenously developed Covid-19 vaccine, has begun at an institute here, a senior official said on Friday.
The vaccine was administered to two recruits on Thursday at the Preventive and Therapeutic Clinical Trial Unit (PTCTU) at the Institute of Medical Sciences and SUM Hospital, the only institute in Odisha chosen by the Indian Council for Medical Research (ICMR) for the human trial of the vaccine, E.Venkata Rao, the principal investigator in Covaxin human trial said.
The indigenous vaccine, which is being developed by Bharat Biotech and ICMR, has received the approval of the Central Drugs Standard Control Organisation (CDSCO) for initiating the third phase trial.